Biologist - In Vivo at Eli Lilly and Company

Indianapolis, Indiana, United States

Apply Now

Not SpecifiedCompensation

Junior (1 to 2 years), Mid-level (3 to 4 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, Biotechnology, Neuroscience, HealthcareIndustries

Requirements

Bachelors or Masters Degree in Biology, Pharmacology, Animal Sciences, Neuroscience, or a related scientific field
2+ years of post-degree academic or industry experience involving in vivo studies

Responsibilities

Design, lead, and conduct in vivo studies from initiation through data delivery, including dosing, tissue collection, and sample processing
Perform all core in vivo dosing techniques, including intravenous, intraperitoneal, subcutaneous, and intracerebroventricular routes
Master and perform rodent surgical techniques for sample collection (e.g., CSF, brain, plasma) and delivery of therapeutics
Execute study-specific workflows, including antibody administration, pharmacokinetic sampling, and brain dissection
Perform supporting biochemical assays (ELISA, Western blot, etc.) for quantification and biomarker readouts
Maintain accurate, organized records of experimental data, protocols, and sample inventories in electronic lab notebooks
Communicate study progress and data clearly to project leads and cross-functional teams
Ensure compliance with IACUC-approved animal protocols and uphold high standards of animal welfare and laboratory safety

Skills

In Vivo Pharmacology

Pharmacokinetics

Rodent Studies

Mouse Models

Antibody PK

Brain Penetration

Target Engagement

Transgenic Models

Knock-in Models

CSF Collection

ICV Injections

Tissue Harvesting

Surgical Procedures

Study Design

Data Analysis

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free